Overview

CKD-391 DDI : Atorvastatin and Ezetimibe in Healthy Volunteers

Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
A randomized open-label, multiple dose, three-treatment, three-period, six-sequence, crossover study to investigate the pharmacokinetic drug interaction between Atorvastatin and Ezetimibe after oral administration in healthy volunteers
Phase:
Phase 1
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical
Treatments:
Atorvastatin
Atorvastatin Calcium
Calcium, Dietary
Ezetimibe